Published in Microbiol Immunol on January 01, 2002
Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship. J Virol (2004) 2.01
Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1. J Virol (2005) 1.50
Herpes simplex virus 1 protein kinase Us3 phosphorylates viral envelope glycoprotein B and regulates its expression on the cell surface. J Virol (2008) 1.19
Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2. J Virol (2009) 1.03
Viral serine/threonine protein kinases. J Virol (2010) 0.99
Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases. Curr Top Microbiol Immunol (2010) 0.86
Felid herpesvirus type 1 infection in cats: a natural host model for alphaherpesvirus pathogenesis. ISRN Vet Sci (2012) 0.81
Herpesviruses and intermediate filaments: close encounters with the third type. Viruses (2011) 0.78
Epithelial Intermediate Filaments: Guardians against Microbial Infection? Cells (2016) 0.77
Phosphorylation and Reorganization of Keratin Networks: Implications for Carcinogenesis and Epithelial Mesenchymal Transition. Biomol Ther (Seoul) (2015) 0.76
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis (2003) 1.98
Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem (2004) 1.86
Palm mutants in DNA polymerases alpha and eta alter DNA replication fidelity and translesion activity. Mol Cell Biol (2004) 1.85
Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J Virol (2003) 1.72
Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J Biol Chem (2005) 1.63
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis (2008) 1.54
Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1. J Virol (2005) 1.50
Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol (2011) 1.50
Characterization of H5N1 highly pathogenic avian influenza virus strains isolated from migratory waterfowl in Mongolia on the way back from the southern Asia to their northern territory. Virology (2010) 1.48
Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7. Dermatology (2006) 1.47
Resistance to influenza A virus infection in transformed cell lines expressing an anti-PB2 monoclonal antibody. Vet J (2013) 1.39
Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol (2008) 1.34
Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. J Virol (2006) 1.33
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis (2008) 1.28
Rapid diagnosis of human herpesvirus 6 infection by a novel DNA amplification method, loop-mediated isothermal amplification. J Clin Microbiol (2004) 1.24
Olfactory transmission of neurotropic viruses. J Neurovirol (2005) 1.23
Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics (2008) 1.21
Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J Gen Virol (2003) 1.21
Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet (2010) 1.20
Herpes simplex virus type 1 UL51 protein is involved in maturation and egress of virus particles. J Virol (2005) 1.19
Rapid diagnosis of herpes simplex virus infection by a loop-mediated isothermal amplification method. J Clin Microbiol (2005) 1.17
Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer. Cancer Lett (2003) 1.15
Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J Virol (2004) 1.15
Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol (2002) 1.15
Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. J Virol (2006) 1.13
Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication. J Virol (2005) 1.13
The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0. Virology (2005) 1.13
Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS One (2011) 1.12
Generation of a transgenic rabbit model of retinal degeneration. Invest Ophthalmol Vis Sci (2008) 1.11
Oncologic outcome of intersphincteric resection for very low rectal cancer. World J Surg (2009) 1.10
Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol (2007) 1.08
Rac is involved in the interkinetic nuclear migration of cortical progenitor cells. Neurosci Res (2009) 1.08
Formation of aggresome-like structures in herpes simplex virus type 2-infected cells and a potential role in virus assembly. Exp Cell Res (2004) 1.06
Identification and characterization of the UL56 gene product of herpes simplex virus type 2. J Virol (2002) 1.06
Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination. J Virol (2008) 1.06
Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes. Microbes Infect (2004) 1.05
Herpes simplex virus type 2 membrane protein UL56 associates with the kinesin motor protein KIF1A. J Gen Virol (2005) 1.05
Subcellular localization of herpes simplex virus type 1 UL51 protein and role of palmitoylation in Golgi apparatus targeting. J Virol (2003) 1.05
Effectiveness of a transanal tube for the prevention of anastomotic leakage after rectal cancer surgery. World J Surg (2014) 1.04
Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis (2009) 1.04
Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1. Brain Res (2002) 1.04
Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003. Virology (2009) 1.04
Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2. J Virol (2009) 1.03
Detection of human herpesvirus 7 DNA by loop-mediated isothermal amplification. J Clin Microbiol (2004) 1.03
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex. PLoS Pathog (2009) 1.03
Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells. Exp Cell Res (2005) 1.01
One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. J Virol Methods (2007) 1.01
Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus. Microbes Infect (2006) 1.01
Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis (2002) 1.01
The unfolded protein response is activated in differentiating epidermal keratinocytes. J Invest Dermatol (2009) 1.01
Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol (2008) 1.01
High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia. J Med Virol (2011) 0.99
Hsp105alpha suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity. J Biol Chem (2003) 0.98
The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus. Virology (2005) 0.98
Mitochondria and viruses. Mitochondrion (2010) 0.98
Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production. J Invest Dermatol (2013) 0.98
Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR. Microbiol Immunol (2002) 0.98
Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer. Ann Surg Oncol (2006) 0.97
Paeoniflorin, a novel heat shock protein-inducing compound. Cell Stress Chaperones (2004) 0.96
Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. J Gen Virol (2009) 0.96
Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man. J Gen Virol (2010) 0.96
Herpes simplex virus 1 protein kinase Us3 and major tegument protein UL47 reciprocally regulate their subcellular localization in infected cells. J Virol (2011) 0.96
Long-term outcomes after intersphincteric resection for low-lying rectal cancer. Ann Surg Oncol (2014) 0.96
Monitoring herpesvirus DNA in three cases of acute retinal necrosis by real-time PCR. J Clin Virol (2004) 0.94
Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases. Cancer Sci (2012) 0.94
Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection. J Med Virol (2006) 0.94
Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis. J Gen Virol (2002) 0.94
Multiplex real-time PCR for the simultaneous detection of herpes simplex virus, human herpesvirus 6, and human herpesvirus 7. Microbiol Immunol (2009) 0.94
Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open (2011) 0.94
Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10. J Dermatol Sci (2008) 0.93
Herpes simplex virus type 2 UL14 gene product has heat shock protein (HSP)-like functions. J Cell Sci (2002) 0.93